The dangerous GP question is what happens after close.

If I were an LP right now, I would ask every GP one question they cannot answer with a slide deck.

What exactly do you do after you buy it?

Not the polite version.

Not "talk me through your value creation approach."

That invites the usual opera.

Operating playbooks.

Functional experts.

Executive networks.

Pricing excellence.

Digital transformation.

Commercial acceleration.

Procurement savings.

Talent upgrade.

All perfectly reasonable words that become much less useful when they float three feet above the actual company.

I would ask for the last three operational improvements the GP personally drove.

Not observed.

Not sponsored.

Not included in a board pack.

Drove.

What was broken.

Who resisted.

What decision got made.

Who owned it.

What changed in the numbers.

How long did it take.

Where did the plan fail.

What did the firm do when management disagreed.

That is where the room gets interesting.

I have seen GPs who can walk through this with painful specificity.

Pricing architecture changed. Discount leakage reduced. Gross margin moved.

Sales routing rebuilt. Speed-to-lead improved. Conversion rose.

Procurement consolidated. Vendor terms reset. Working capital released.

They know the names. The meetings. The ugly bits. The number before and after.

I have also seen GPs answer with case studies that sound like they were grown in a fundraising laboratory.

Plenty of nouns.

Very little scar tissue.

The difference matters.

LPs do not need another explanation of private equity as a concept. They need to know whether the GP can change the asset when the market does not do the work for them.

The most dangerous question in PE is not about returns.

Returns can be framed.

Operational capability has to be described.

And if the answer cannot survive five follow-up questions, you already know what you are looking at.